Results 231 to 240 of about 21,540 (276)

Structural flexibility of the nicotinamide group of NADH in butanol dehydrogenase YqdH from Fusobacterium nucleatum. [PDF]

PLoS One
Bai X, Nam KH, Xu Y.
europepmc   +1 more source

Engineering bifidobacteria to deliver CRISPR antimicrobials targeting oncogenic <i>Fusobacterium nucleatum</i> in colorectal tumors. [PDF]

Ann Med Surg (Lond)
Mehmood MS, Qamar T, Amjad F, Danaf N.
europepmc   +1 more source

<i>Fusobacterium nucleatum-</i>Induced Pyopneumothorax: A Rare but Serious Clinical Entity. [PDF]

Infect Drug Resist
Chen Y, Yu C, Chai J, Chai M, Xiao Y, Loong H, Xu D, Wang L.   +7 more
europepmc   +1 more source

Fusobacterium nucleatum enhances oxaliplatin resistance in colon cancer by increasing PVT1 expression. [PDF]

J Transl Med
Gao K, Zhang J, Liu C, Yang Y, Wang J, Zhang J, Ma H, Wang F, Zhao L, Wang G.   +9 more
europepmc   +1 more source

Fusobacterium nucleatum and non-coding RNAs: orchestrating oncogenic pathways in colorectal cancer. [PDF]

Gut Pathog
Sadeghloo Z, Ebrahimi S, Hakemi-Vala M, Totonchi M, Sadeghi A, Fatemi N.   +5 more
europepmc   +1 more source

<i>Fusobacterium nucleatum</i> as a two-hit amplifier in colorectal cancer pathogenesis: intersection of local and systemic mechanisms via the gut-kidney axis. [PDF]

Fujita Med J
Shimizu H.
europepmc   +1 more source

Fusobacterium nucleatum — symbiont, opportunist and oncobacterium [PDF]

Nature Reviews Microbiology, 2018
Fusobacterium nucleatum has long been found to cause opportunistic infections and has recently been implicated in colorectal cancer; however, it is a common member of the oral microbiota and can have a symbiotic relationship with its hosts. To address this dissonance, we explore the diversity and niches of fusobacteria and reconsider historic ...
Caitlin A Brennan, Wendy S Garrett, Garrett Wendy S   +2 more
exaly   +3 more sources